Why distance, not size, governs the next move
The instinct in expansion planning is to rank candidate markets by their attractiveness: size, growth, margin, competitive slack. This is the wrong primary axis. A market's value to you is conditional on your ability to actually operate in it, and that ability is a function of how far the market sits from the capabilities you already possess. The adjacent possible is the set of markets reachable from your current position using assets you can redeploy and capabilities you can stretch rather than rebuild. A large market that requires a new regulatory competence, a new distribution model, and a new buyer relationship is not, in any operational sense, available to you yet — it is a market you would have to become a different company to enter.
The mechanism that makes adjacency matter is capability compounding. Each market you enter successfully deposits new assets — a regulatory filing, a logistics lane, a reference customer, a localized product, a trained sales motion. Those deposits become the launch points for the next move. Expansion is therefore not a portfolio of independent bets but a path, where the reachable frontier widens with every step taken and narrows every time you skip one.
The failure mode: stranded capability
The characteristic failure of expansion is not that a distant market proves unattractive — it usually is attractive, which is why it tempted you. The failure is the stranded leap: you commit to a market two or three steps beyond your frontier because its size justified the spreadsheet, and you arrive without the intermediate capabilities that would have made operating there cheap. Now you are building regulatory, distribution, and brand competence simultaneously, under revenue pressure, in a market where incumbents built those same capabilities sequentially over a decade. The capital you deployed does not compound, because the assets you built are specific to a beachhead you cannot defend. This is how well-funded firms enter five countries and hold none.
Stranding has a quiet variant that is easier to miss. A leap can succeed commercially and still strand you strategically if the capabilities it demanded share nothing with your core. You win the distant market but learn nothing transferable; the win is an island, and the next move is as far away as the last one was.
Reading the frontier before you commit
Sequencing well requires naming, before each move, exactly which assets carry over and which must be built new. The discipline is to keep the count of net-new capabilities per step low — ideally one — so that every entry is mostly a redeployment with a single genuine stretch. Before committing to a market, force the answer to these:
- Which existing assets — regulatory, distribution, brand, product, talent — transfer to this market without rebuild?
- What is the single hardest new capability this market demands, and does building it widen the frontier toward markets after this one?
- If this entry fails, do the assets we built remain useful for an alternative next step, or are they stranded?
The decision implication: sequence, then size
The practical rule inverts the usual order of analysis. First map the adjacency graph — which markets are reachable from here, and which markets each of those would in turn unlock. Then, and only then, let attractiveness break ties among the genuinely reachable. A smaller market that opens three larger ones behind it dominates a larger market that opens nothing, because you are not choosing a destination but a path through the graph. The question is never "which market is best?" but "which reachable market most widens what becomes reachable next?"
This carries a cost worth stating plainly. Sequencing means deliberately declining markets you could fund today, accepting slower near-term revenue in exchange for a frontier that keeps widening. The trade-off is real, and in a genuine land-grab where a competitor is racing to lock in a winner-take-most position, adjacency discipline can lose to speed. The judgment a strategist owes the board is to distinguish the two regimes — to know when patience compounds and when it merely cedes ground — and to say which one you are in before the capital is committed, not after.